258 related articles for article (PubMed ID: 22522141)
1. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
Pande C; Kumar A; Sarin SK
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
[TBL] [Abstract][Full Text] [Related]
2. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
[TBL] [Abstract][Full Text] [Related]
3. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
Lontos S; Gow PJ; Vaughan RB; Angus PW
J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
[TBL] [Abstract][Full Text] [Related]
4. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
5. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
[TBL] [Abstract][Full Text] [Related]
6. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
Sandhu BS; Gupta R; Sharma J; Singh J; Murthy NS; Sarin SK
J Gastroenterol Hepatol; 2005 Apr; 20(4):599-605. PubMed ID: 15836710
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
Assem M; Elsabaawy M; Abdelrashed M; Elemam S; Khodeer S; Hamed W; Abdelaziz A; El-Azab G
Hepatol Int; 2016 Mar; 10(2):377-85. PubMed ID: 26660707
[TBL] [Abstract][Full Text] [Related]
9. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
10. A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
Das A
Am J Gastroenterol; 1998 Oct; 93(10):1895-900. PubMed ID: 9772051
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
Mostafa T; Badra G; Abdallah M
Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
[TBL] [Abstract][Full Text] [Related]
12. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin.
Marciano S; Dirchwolf M; Diaz JM; Bermudez C; Gutierrez-Acevedo MN; Barcán LA; Smud A; Giunta D; Gadano AC
Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):540-546. PubMed ID: 30557229
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis.
Mücke MM; Mücke VT; Graf C; Schwarzkopf KM; Ferstl PG; Fernandez J; Zeuzem S; Trebicka J; Lange CM; Herrmann E
Clin Transl Gastroenterol; 2020 Aug; 11(8):e00223. PubMed ID: 32955202
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
16. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
Corradi F; Brusasco C; Fernández J; Vila J; Ramirez MJ; Seva-Pereira T; Fernández-Varo G; Mosbah IB; Acevedo J; Silva A; Rocco PR; Pelosi P; Gines P; Navasa M
Dig Liver Dis; 2012 Mar; 44(3):239-44. PubMed ID: 22119621
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.
Terg R; Fassio E; Guevara M; Cartier M; Longo C; Lucero R; Landeira C; Romero G; Dominguez N; Muñoz A; Levi D; Miguez C; Abecasis R
J Hepatol; 2008 May; 48(5):774-9. PubMed ID: 18316137
[TBL] [Abstract][Full Text] [Related]
18. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
19. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
[TBL] [Abstract][Full Text] [Related]
20. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.
Fernández J; Navasa M; Planas R; Montoliu S; Monfort D; Soriano G; Vila C; Pardo A; Quintero E; Vargas V; Such J; Ginès P; Arroyo V
Gastroenterology; 2007 Sep; 133(3):818-24. PubMed ID: 17854593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
